Us Bancorp \De\ Sorrento Therapeutics, Inc. Transaction History

Us Bancorp \De\

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.74 - $1.83 $7,311 - $18,080	-9,880 Reduced 23.59%	32,000 $28,000
Q3 2022 Oct 27, 2022	BUY	$1.51 - $2.88 $7,317 - $13,956	4,846 Added 13.09%	41,880 $66,000
Q2 2022 Aug 01, 2022	SELL	$1.24 - $2.33 $5,922 - $11,128	-4,776 Reduced 11.42%	37,034 $74,000
Q1 2022 May 11, 2022	BUY	$2.0 - $4.9 $19,882 - $48,710	9,941 Added 31.19%	41,810 $97,000
Q4 2021 Feb 11, 2022	BUY	$4.65 - $7.23 $29,150 - $45,324	6,269 Added 24.49%	31,869 $149,000
Q3 2021 Nov 10, 2021	SELL	$7.41 - $10.99 $1,778 - $2,637	-240 Reduced 0.93%	25,600 $195,000
Q2 2021 Aug 05, 2021	BUY	$6.35 - $10.0 $14,922 - $23,500	2,350 Added 10.0%	25,840 $251,000
Q1 2021 Apr 28, 2021	BUY	$7.03 - $16.51 $41,216 - $96,798	5,863 Added 33.26%	23,490 $195,000
Q4 2020 Feb 04, 2021	BUY	$5.76 - $11.95 $3,346 - $6,942	581 Added 3.41%	17,627 $120,000
Q3 2020 Nov 10, 2020	BUY	$6.17 - $18.82 $33,268 - $101,477	5,392 Added 46.27%	17,046 $190,000
Q2 2020 Aug 07, 2020	BUY	$1.73 - $6.76 $20,161 - $78,781	11,654 New	11,654 $74,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.